Is Jyothy Labs overvalued or undervalued?

As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive. The company is currently considered fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA ratio of 21.82, and a ROCE of 29.33%.
In comparison to its peers, Jyothy Labs has a significantly lower valuation than Hindustan Unilever, which has a PE ratio of 53.63, and Nestle India, with a PE ratio of 81.21. Despite its recent stock performance underperforming the Sensex, with a YTD return of -21.62% compared to the Sensex's 6.50%, the company's solid ROCE and attractive valuation relative to its peers suggest it remains a viable investment option.